Interestingly, MDA-MB-231 triple-negative breast cancer cells and normal AB589 mammary epithelial cells express GRM1; however, treatment of cells with the mGluR1 antagonist BAY 36-7620 had a significant effect on cell growth only in breast cancer cells (213). This evidence concerns the gene GRM1 and triple-negative breast carcinoma.